These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 30551491)

  • 1. Rosmarinic acid reduces the resistance of gastric carcinoma cells to 5-fluorouracil by downregulating FOXO4-targeting miR-6785-5p.
    Yu C; Chen DQ; Liu HX; Li WB; Lu JW; Feng JF
    Biomed Pharmacother; 2019 Jan; 109():2327-2334. PubMed ID: 30551491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of miRNA-200c on chemotherapy-resistance and cell proliferation of gastric cancer SGC7901/DDP cells.
    Chen Y; Zuo J; Liu Y; Gao H; Liu W
    Chin J Cancer; 2010 Dec; 29(12):1006-11. PubMed ID: 21114921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
    Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
    Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal effect of rosmarinic acid on multidrug resistance in SGC7901/Adr cell.
    Li FR; Fu YY; Jiang DH; Wu Z; Zhou YJ; Guo L; Dong ZM; Wang ZZ
    J Asian Nat Prod Res; 2013; 15(3):276-85. PubMed ID: 23421517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
    Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
    Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reversion of multidrug resistance of human gastric cancer SGC7901/DDP cells by E2F-1 gene silencing].
    Lian C; Yang J; Wang X; Xie Y; Xiao Q
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):171-6. PubMed ID: 24785275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
    Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
    Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of secretory clusterin (sCLU) induces chemotherapy resistance in human gastric cancer cells by targeting miR-195-5p.
    Mu L; Yang F; Guo D; Li P; Zhang M
    Bioengineered; 2020 Dec; 11(1):472-483. PubMed ID: 32250192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
    Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
    Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
    Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
    Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-129-5p inhibits proliferation of gastric cancer cells through targeted inhibition on HMGB1 expression.
    Feng J; Guo J; Wang JP; Chai BF
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3665-3673. PubMed ID: 32329842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells.
    Wang CQ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3771-3778. PubMed ID: 31115003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN.
    Jin YY; Chen QJ; Xu K; Ren HT; Bao X; Ma YN; Wei Y; Ma HB
    Mol Cell Biochem; 2016 Nov; 422(1-2):161-170. PubMed ID: 27644195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal Effect of Dihydromyricetin on Multiple Drug Resistance in SGC7901/5-FU Cells.
    Wu M; Jiang M; Dong T; Xu L; Lv J; Xue M; Huang M
    Asian Pac J Cancer Prev; 2020 May; 21(5):1269-1274. PubMed ID: 32458632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
    Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
    Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAX1BP1 downregulation by EBV-miR-BART15-3p enhances chemosensitivity of gastric cancer cells to 5-FU.
    Choi H; Lee SK
    Arch Virol; 2017 Feb; 162(2):369-377. PubMed ID: 27757686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.
    Liu H; Yin Y; Hu Y; Feng Y; Bian Z; Yao S; Li M; You Q; Huang Z
    Pathol Res Pract; 2016 Jul; 212(7):643-9. PubMed ID: 27173050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.